Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) Earns 0 Analysts Hold Rating
Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) registered a 5.21% increase, still its new closing price is 28.95% up from the company’s 1 year high of 0.64.It posted -1.96% …
Posts tagged Immune Pharmaceuticals
These Brokerage Research Findings Are Noteworthy: FireEye, Inc. (NASDAQ:FEYE), Immune Pharmaceuticals, Inc. (NASDAQ:IMNP)
FireEye, Inc. (NASDAQ:FEYE) showed a decline of -1.72% from the market’s prior closing price. That fall sent the price at $12.60 per share as of …
Worth Watching Stock Analyst Recommendations: aTyr Pharma, Inc. (NASDAQ:LIFE), Immune Pharmaceuticals, Inc. (NASDAQ:IMNP)
aTyr Pharma, Inc. (NASDAQ:LIFE) showed a growth of 32.65% from the market’s prior closing price. That gain sent the price at $3.25 per share as …